AGREEMENT CONTAINING CONSENT ORDERDecember 29th, 2008
FiledDecember 29th, 2008The Federal Trade Commission (“Commission”), having initiated an investigation of the proposed acquisition by Respondent King Pharmaceuticals, Inc. of Respondent Alpharma Inc., (hereinafter collectively referred to as (“Proposed Respondents”) and it now appearing that Proposed Respondents are willing to enter into this Agreement Containing Consent Order (“Consent Agreement”) to divest certain assets and providing for other relief: